-
February 17: The Week in Cancer News
More older women with breast cancer may not need radiation therapy, and supply shortages hinder bladder cancer treatment.
by Kevin McLaughlin
-
Spouses of Cancer Patients Have Greater Risk of Psychiatric Disorders
Mental health support in the wake of a cancer diagnosis often doesn’t extend to spouses.
by Karon Warren
-
February 10: The Week in Cancer News
Patients who receive certain forms of chemo face long-term risk for heart failure, and screening levels for certain cancers remain below expectations.
by Thomas Celona
-
Consider Immunotherapy Before Surgery for Melanoma
Immunotherapy before surgery is proving to be an effective treatment against melanoma.
by Sandra Gordon
-
February 3: The Week in Cancer News
Group says more women should consider removing fallopian tubes to lower ovarian cancer risk, and treatment guidelines can lead to arbitrary age cutoffs.
by Eric Fitzsimmons
-
January 27: The Week in Cancer News
Many women underestimate dense breast effect on cancer risk, and FDA approves targeted therapy for colorectal cancer.
by Kevin McLaughlin
-
An Evidence-Based Guide to Integrative Medicine
ASCO and the Society for Integrative Oncology issue recommendations for integrative medicine approaches that have been supported with research.
by Teresa Bergen
-
January 20: The Week in Cancer News
Women experience faster decline in physical function after cancer, and treatment quality for lung cancer varies across the US.
by Marci A. Landsmann
-
Comparing Costs of At-Home Colorectal Screening Tests
Cologuard and FIT have been found equally effective at screening for colorectal cancer and are widely used, but FIT is a fraction of the cost of Cologuard.
by Jon Kelvey
-
January 13: The Week in Cancer News
Women over 65 diagnosed at later stages of cervical cancer, and Black and Hispanic patients prescribed fewer opioids for end-of-life cancer care.
by Eric Fitzsimmons
Cancer Talk
Injection Immunotherapies Get FDA Approval
Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore